Because miR-21 contains a short seed region (which dictates complementarity to target mRNA transcripts), it is thought that miR-21 has multiple regulatory targets that are associated with cancer progression, such as programmed cell death 4 (PDCD4) [3, 11], TPM1 [10], phosphatase and tensin homologue (PTEN) [12], myristoylated alanine-rich protein kinase c substrate (MARCKS) [13], and maspin [14]. The gene discussed is MARCKS; the disease is cancer.